Private Wealth Advisors (California)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-20,166
Closed -$1.14M 100
2021
Q3
$1.14M Sell
20,166
-79
-0.4% -$5.2K 0.27% 65
2021
Q2
$1.35M Buy
20,245
+2,048
+11% +$134K 0.41% 47
2021
Q1
$1.15M Buy
18,197
+1,785
+11% +$111K 0.39% 42
2020
Q4
$1.06M Buy
16,412
+648
+4% +$39.8K 0.37% 42
2020
Q3
$950K Buy
+15,764
New +$949K 0.49% 30

Other funds holding BMY

Private Wealth Advisors (California)'s BMY Position: Q4 2021 in Review

Private Wealth Advisors (California) sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 20,166 shares — an estimated $1.14M sold.

Private Wealth Advisors (California) first reported a position in BMY in Q3 2020 and held it in 5 quarters. The position peaked at $1.35M in Q2 2021. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

  • Private Wealth Advisors (California) reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
  • Private Wealth Advisors (California) sold 20,166 Bristol-Myers Squibb shares in Q4 2021, an estimated $1.14M.
  • Private Wealth Advisors (California) first reported a position in Bristol-Myers Squibb in Q3 2020 and held it in 5 quarters.
  • Private Wealth Advisors (California)'s Bristol-Myers Squibb position peaked at $1.35M in Q2 2021.
  • 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Private Wealth Advisors (California)'s 13F filing for Q4 2021, filed 11 Feb 2022.